Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.21% |
| 2 | Healthcare | 10.45% |
| 3 | Technology | 8.65% |
| 4 | Financials | 8.6% |
| 5 | Consumer Discretionary | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Argan
AGX
$5.91B
| $2.3M | ﹤0.01% |
57,407
+48,434
| +540% | +$1.86M |
|
|
BHR
2502
Braemar Hotels & Resorts
BHR
$141M
| $2.3M | ﹤0.01% |
+257,610
| New | +$2.41M |
|
|
DOCU
2503
DocuSign
DOCU
$12.2B
| $2.3M | ﹤0.01% |
30,983
-790,741
| -96% | -$54.3M |
|
|
KSU
2504
DELISTED
Kansas City Southern
KSU
| $2.29M | ﹤0.01% |
14,946
-92,432
| -86% | -$13.6M |
|
|
SRC
2505
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $2.29M | ﹤0.01% |
46,503
-150,163
| -76% | -$7.47M |
|
2506
Korro Bio
KRRO
$193M
| $2.27M | ﹤0.01% |
+2,595
| New | +$2.02M |
|
2507
DigitalBridge
DBRG
$2.99B
| $2.27M | ﹤0.01% |
119,616
-78,807
| -40% | -$1.62M |
|
2508
PUT
Zymeworks
ZYME
$2.04B
| $2.27M | ﹤0.01% |
+50,000
| New | +$1.82M |
|
2509
Applied Optoelectronics
AAOI
$9.05B
| $2.27M | ﹤0.01% |
+191,055
| New | +$2.04M |
|
|
XOMA
2510
DELISTED
Xoma
XOMA
| $2.27M | ﹤0.01% |
83,150
+68,991
| +487% | +$1.54M |
|
|
AXE
2511
DELISTED
Anixter International Inc
AXE
| $2.27M | ﹤0.01% |
24,635
+19,413
| +372% | +$1.57M |
|
2512
Scansource
SCSC
$1.15B
| $2.27M | ﹤0.01% |
61,308
+53,511
| +686% | +$1.82M |
|
2513
Worthington Enterprises
WOR
$2.8B
| $2.26M | ﹤0.01% |
87,049
-61,416
| -41% | -$1.44M |
|
2514
Howmet Aerospace
HWM
$105B
| $2.26M | ﹤0.01% |
95,903
-24,193
| -20% | -$540K |
|
2515
Appian
APPN
$3.02B
| $2.26M | ﹤0.01% |
59,202
+33,868
| +134% | +$1.46M |
|
|
SAFM
2516
CALL
DELISTED
Sanderson Farms Inc
SAFM
| $2.26M | ﹤0.01% |
+12,800
| New | +$2.02M |
|
2517
Ligand Pharmaceuticals
LGND
$5.57B
| $2.25M | ﹤0.01% |
34,650
+4,536
| +15% | +$303K |
|
2518
PUT
Archer Daniels Midland
ADM
$39.3B
| $2.25M | ﹤0.01% |
48,600
-9,700
| -17% | -$414K |
|
|
NOAH
2519
Noah Holdings
NOAH
$592M
| $2.25M | ﹤0.01% |
63,483
-198,891
| -76% | -$6.07M |
|
2520
Ooma
OOMA
$627M
| $2.24M | ﹤0.01% |
169,522
+93,405
| +123% | +$1.14M |
|
|
PDLI
2521
DELISTED
PDL BioPharma, Inc.
PDLI
| $2.24M | ﹤0.01% |
690,871
+442,251
| +178% | +$1.28M |
|
2522
Leidos
LDOS
$17.7B
| $2.24M | ﹤0.01% |
22,894
-85,856
| -79% | -$7.57M |
|
2523
Arq
ARQ
$93.9M
| $2.24M | ﹤0.01% |
213,247
+198,841
| +1,380% | +$2.38M |
|
2524
CALL
CONMED
CNMD
$1.5B
| $2.24M | ﹤0.01% |
20,000
+15,000
| +300% | +$1.6M |
|
|
FLXN
2525
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $2.24M | ﹤0.01% |
108,072
+97,228
| +897% | +$1.64M |
|
Similar funds
Israel Englander's Q4 2019 Portfolio in Review
As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Israel Englander deployed $4.28B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Israel Englander opened 829 new positions and closed 796 in Q4 2019.
- Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.